Shows & Events 2012

Event or Convention Location Exhibit Dates Exhibit No.
Texas Med Center Houston, TX January 20
UCSD San Diego, CA February 9
Harvard Medical School Boston, MA March 22
American Association For Cancer Research (AACR) Chicago, IL April 1-4 3900
Experimental Biology (EB) San Diego, CA April 21-25 1101
American Association of Immunologists (AAI) Boston, MA May 4-8 404
Canadian Neuroscience (CAN) Vancouver, Canada TBA TBA
The Endocrine Society Houston, TX June 23-26 TBA
Federation of European Neurosciences (FENS) Barcelona, ES July 14-18 56A
UCLA Los Angeles, CA October 4 TBA
ITO Boston, MA TBA TBA
Society for Neuroscience (SFN) New Orleans, LA October 13-17 TBA
American Association of Laboratory Animal Science (AALAS) Minneapolis, MN November 4-8 TBA

Researchers are saying...

“In preliminary studies using this model, we observed severe side effects with 5-FU doses beyond 25 mg/kg biweekly injections (mice developed skin ulcers, bleeding and severe diarrhea). Thus, we chose to deliver 5-FU by continuous infusion at an equivalent cumulative dose in order to minimize toxicity. Additionally, studies have demonstrated an increased efficacy of chemotherapeutic agents when administered continuously.” Stoeltzing et al. Int. J. Cancer 2003;104:496-503.